Evidence map›Paper›PMID 11179299›Full record

ArticleInfection and immunity2001

Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.

W G Hu, J Chen, J C McMichael, X X Gu

Abstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. TLR2 regulatesVirulence · 2024
    Article
  2. Review
  3. Vaccine targets against Moraxella catarrhalis.Expert opinion on therapeutic targets · 2016
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

W G HuLaboratory of Immunology, National Institute on Deafness and Other Communication Disorders, Rockville, Maryland 20850, USA.
J Chen
J C McMichael
X X Gu
National Institute on Deafness and Other Communication Disorders · USHuman Immunome Project · US

Funding

VACCINE DEVELOPMENT OF NONTYPEABL HAEMOPHILUS INFLUENZAEZ01DC000019 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI GU, XIN-XING · 1994 to 2008
$1.5M
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalisZIADC000019 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI GU, XIN-XING · 2009 to 2010
$1.3M
PATHOGENESIS/IMMUNOBIOLOGY OF NONTYPEABLE HAEMOPHILUS INFLUENZAE OTITIS MEDIAZ01DC000020 · NIDCD · DEAFNESS &OTHER COMMUNICATION DISORDERS · PI GU, XIN-XING XING · 1994 to 2001
–
6 · The paper itself

Abstract

A monoclonal antibody (MAb), designated MAb 8E7 (immunoglobulin G3), specific for Moraxella catarrhalis lipooligosaccharide (LOS) was evaluated for its functional activity in vitro and in a mouse model of colonization. Enzyme-linked immunosorbent assay (ELISA) demonstrated that the MAb 8E7 could be prepared to a high titer against LOS of the homologous strain 035E, and that it had bactericidal activity. MAb 8E7 reacted with M. catarrhalis serotype A and C LOSs but not serotype B LOS, as measured by ELISA and Western blotting. On the basis of published structures of LOSs, this suggests that the epitope recognized by MAb 8E7 is directed to a common sequence of either alpha-GlcNAc-(1-->2)-beta-Glc-(1--> at the branch substituting position 4 of the trisubstituted Glc residue or a terminal tetrasaccharide alpha-Gal-(1-->4)-beta-Gal-(1-->4)-alpha-Glc-(1-->2)-beta-Glc-(1--> at the branch substituting position 6 of the trisubstituted Glc residue. In a whole-cell ELISA, MAb 8E7 reacted with 70% of the 30 wild-type strains and clinical isolates tested. Immuno-electron microscopy demonstrated that MAb 8E7 reacted with a cell surface-exposed epitope of LOS on strain O35E. MAb 8E7 inhibited the adherence of strain O35E to Chang conjunctival epithelial cells by 90%. Passive immunization with MAb 8E7 could significantly enhance the clearance of strain O35E from mouse lungs in an aerosol challenge mouse model. This enhanced bacterial clearance was inhibited when MAb 8E7 was absorbed by M. catarrhalis serotype A LOS, indicating that the M. catarrhalis LOS-directed antibody may play a major role in the enhancement of M. catarrhalis clearance from lungs. These data suggest that MAb 8E7, which recognizes surface-exposed LOS of M. catarrhalis, is a protective antibody against M. catarrhalis.

Indexed as

Immunization, PassiveAnimalsAntibodies, BacterialAntibodies, MonoclonalAntibody SpecificityAntigens, SurfaceEpitopesFemaleLipopolysaccharidesLung DiseasesMiceMice, Inbred BALB CMicroscopy, ImmunoelectronMoraxella catarrhalisNeisseriaceae InfectionsSerotypingAntibodies, BacterialAntibodies, MonoclonalAntigens, SurfaceEpitopeslipid-linked oligosaccharidesLipopolysaccharides

Identifiers

PMID11179299
PMCPMC98028
OpenAlexW2049550818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.